Talk:Rifalazil

	This article was reviewed by member(s) of WikiProject Articles for creation. The project works to allow users to contribute quality articles and media files to the encyclopedia and track their progress as they are developed. To participate, please visit the project page for more information.Articles for creationWikipedia:WikiProject Articles for creationTemplate:WikiProject Articles for creationAfC articles
	This article was accepted on 21 November 2012 by reviewer FreeRangeFrog (talk · contribs).

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Needs context edit

Latest comment: 11 years ago1 comment1 person in discussion

Rifleman 82 (talk) 03:57, 17 December 2012 (UTC)Reply

Reactions edit

C₉H₂₃NO₆P₂ + C₄H₄O₃ + C₅₁C₆₄N₄O₁₃ + C₄H₆BrClO → C₆₀H₇₉N₅O₂₃P₂^[1]

This reaction exhibits the creation of the molecule ryfamicin VIII. Ryfamicin is the original molecule of which rifalazil is the derivative. The purpose of this reaction is to use rifalazil to make a different derivative of the molecule so the substance can be delivered to osseous tissue in the body. This allows the medication to be released at different points in time to the rest of the body in through the blood stream as opposed to all at once.

References

^ Reddy, Ranga; Dietrich, Evelyne; Lafontaine, Yanick; Houghton, Tom J.; Belanger, Odette; Dubois, Anik; Arhin, Francis F.; Sarmiento, Ingrid; Fadhil, Ibtihal (2008). "Bisphosphonated Benzoxazinorifamycin Prodrugs for the Prevention and Treatment of Osteomyelitis". ChemMedChem. 3 (12): 1863–8. doi:10.1002/cmdc.200800255. PMID 18973169.

Add topic

[1] Reddy, Ranga; Dietrich, Evelyne; Lafontaine, Yanick; Houghton, Tom J.; Belanger, Odette; Dubois, Anik; Arhin, Francis F.; Sarmiento, Ingrid; Fadhil, Ibtihal (2008). "Bisphosphonated Benzoxazinorifamycin Prodrugs for the Prevention and Treatment of Osteomyelitis". ChemMedChem. 3 (12): 1863–8. doi:10.1002/cmdc.200800255. PMID 18973169.

[1]